研究单位：[1]Cstone Pharmaceuticals[2]The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China[3]Anhui Provincial Hospital,Hefei,Anhui,China[4]Hefei Second People's Hospital,Hefei,Anhui,China[5]The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China[6]The Second Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China[7]Beijing Friendship Hospital, Capital Medical University,Beijing,Beijing,China[8]Beijing Tsinghua Changgung Hospital,Beijing,Beijing,China[9]Peaking University International Hospital,Beijing,Beijing,China[10]Chongqing General Hospital,Chongqing,Chongqing,China[11]Special Medical Center of The People's Liberation Army of China,Chongqing,Chongqing,China[12]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China[13]Fujian Cancer Hospital,Fuzhou,Fujian,China[14]The First Affiliated Hospital of Xiamen University,Xiamen,Fujian,China[15]The First People's Hospital of Foshan,Foshan,Guangdong,China[16]Cancer Center of Guangzhou Medical University,Guangzhou,Guangdong,China[17]Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou,Guangdong,China[18]Guangdong Provincial People's Hospital,Guangzhou,Guangdong,China[19]Jiangmen Central Hospital,Jiangmen,Guangdong,China[20]Jieyang People's Hospital,Jieyang,Guangdong,China[21]Affiliated Tumor Hospital of Shantou University Medical College,Shantou,Guangdong,China[22]The Fifth Affiliated Hospital of Sun Yat sen University,Zhuhai,Guangdong,China[23]Guangxi Medical University Affiliated Tumor Hospital,Nanning,Guangxi,China[24]Hainan General Hospital,Haikou,Hainan,China[25]The Second Affiliated Hospital of Hainan Medical University,Haikou,Hainan,China[26]Affiliated Hospital of Chengde Medical University,Chengde,Hebei,China[27]Handan Central Hospital,Handan,Hebei,China[28]Shijiazhuang People's Hospital,Shijiazhuang,Hebei,China[29]The Affiliated Tumor Hospital of Harbin Meidical University,Haerbin,Heilongjiang,China[30]Anyang Cancer Hospital,Anyang,Henan,China[31]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China[32]Nanyang Central Hospital,Nanyang,Henan,China[33]Nanyang First People's Hospital,Nanyang,Henan,China[34]Puyang Oilfield General Hospital,Puyang,Henan,China[35]Xinxiang First People's Hospital,Xinxiang,Henan,China[36]Henan Cancer Hospital,Zhengzhou,Henan,China[37]Henan Provincial People's Hospital,Zhengzhou,Henan,China[38]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China[39]Hubei Cancer Hospital,Wuhan,Hubei,China[40]Tongji Medical College of HUST, Tongji Medical College Huazhong University of Science and Technology,Wuhan,Hubei,China[41]Wuhan Fifth Hospital,Wuhan,Hubei,China[42]Wuhan Union Hospital,Wuhan,Hubei,China[43]Hunan Cancer Hospital,Changsha,Hunan,China[44]Changzhou Tumor Hospital,Changzhou,Jiangsu,China[45]Huai'an First People's Hospital,Huai'an,Jiangsu,China[46]Jiangsu Province Hospital,Nanjing,Jiangsu,China[47]Jiangxi Cancer Hospital,Nanchang,Jiangxi,China[48]The First Affiliated Hospital Of Nanchang University,Nanchang,Jiangxi,China[49]Jilin Cancer Hospital,Changchun,Jilin,China[50]The Second Hospital of Jilin University,Changchun,Jilin,China[51]Tonghua Central Hospital,Tonghua,Jilin,China[52]Liaoning Cancer Hospital and Institute,Shenyang,Liaoning,China[53]Jinan central Hospital,Jinan,Shandong,China[54]Shandong Cancer Hospital,Jinan,Shandong,China[55]Linyi Cancer Hospital,Linyi,Shandong,China[56]The Affiliated Hospital of Qingdao University,Qingdao,Shandong,China[57]Shanghai East Hospital,Shanghai,Shanghai,China,201203[58]Shanghai Chest Hospital,Shanghai,Shanghai,China[59]Linfen Central Hospital,Linfen,Shanxi,China[60]Shanxi Provincial Cancer Hospital,Taiyuan,Shanxi,China[61]Chengdu Fifith people's hospital,Chengdu,Sichuan,China[62]Sichuan Provincial People's Hospital,Chengdu,Sichuan,China[63]West China Hospital Sichuan University,Chengdu,Sichuan,China[64]The Affiliated Ho
研究目的：
Phase III Study to Investigate the Efficacy and Safety of CS1001 or Placebo in Combination with FP as First-Line Therapy in Subjects with Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
